Associated Papers
PIK3CA mutations in endocrine-resistant breast cancer.
Schagerholm C et al.
Scientific Reports, 2024
38822093 (PubMed )
Supplement: 41598_2024_62664_MOESM1_ESM.pdf
Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216.
Walls M et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2014
The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors.
Stehr H et al.
Molecular Cancer, 2011
21575214 (PubMed )
Supplement: 1476-4598-10-54-S3.XLS › mutations.txt
Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
Shibata T et al.
Cancer Letters, 2009
A gene-alteration profile of human lung cancer cell lines.
Blanco R et al.
Human Mutation, 2009
Select a paper to view details